ACM Research Reports Third Quarter 2024 Results

Rhea-AI Summary

ACM Research (NASDAQ: ACMR) reported strong Q3 2024 results with record revenue of $204 million, up 21% year-over-year. The company achieved a gross margin of 51.4% and diluted EPS of $0.45. Total shipments reached $261 million, up 23% from Q3 2023. ACM has raised its fiscal year 2024 revenue guidance to $725-745 million from the previous $695-735 million range. The company's Ultra C Tahoe cleaning tool achieved a major breakthrough, now matching single-wafer cleaning tool performance while reducing chemical consumption by up to 75%. ACM also expanded its U.S. presence with a new Oregon facility purchase and opened a new R&D facility in Lingang, China.

Positive

• Revenue increased 21% YoY to $204 million in Q3 2024
• Raised FY2024 revenue guidance to $725-745 million
• Strong gross margin of 51.4%, exceeding long-term target of 40-45%
• Operating income grew to $44.2 million from $33.2 million YoY
• Total shipments increased 23% YoY to $261 million
• Cash position remained strong at $369.1 million

Negative

• Gross margin declined to 51.4% from 52.5% YoY
• Operating expenses increased 10% YoY

Insights

Financial Analyst

ACM Research delivered a strong Q3 2024 with impressive metrics across the board. $204.0M revenue represents 21% YoY growth, while maintaining a robust gross margin of 51.4%, well above their target range of 40-45%. The diluted EPS of $0.45 shows solid profitability improvement from $0.39 last year.

Key growth drivers include increased sales in single wafer cleaning, Tahoe systems and ECP equipment. The raised FY2024 revenue guidance to $725-745M from $695-735M signals strong business momentum. With $369.1M in cash and equivalents, the company maintains a healthy balance sheet to support expansion.

The Lingang facility launch and Oregon facility purchase demonstrate strategic investments in both Asian and US markets, positioning for broader market penetration.

Tech Industry Analyst

The technological breakthroughs in ACM's Ultra C Tahoe cleaning tool represent a significant competitive advantage. The system now matches single-wafer cleaning performance while reducing sulfuric acid consumption by up to 75%, addressing both performance and environmental concerns critical in semiconductor manufacturing.

The expansion into panel-level packaging with new tools like Ultra C bev-p positions ACM well in the growing advanced packaging market, particularly important for AI chip manufacturing. The US customer orders for wafer-level packaging tools indicate successful market diversification beyond China, though China remains their primary growth driver.

FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its third quarter ended September 30, 2024.

"I am pleased to report another strong quarter for ACM, with record revenue and shipments, good profitability, and positive cash flow from operations," said ACM’s President and Chief Executive Officer, Dr. David Wang. "We believe our results demonstrate ACM’s role as an innovator, delivering world-class tools that drive value for our customers and strengthen our position in the global market. Tahoe is gaining momentum with multiple logic and memory customers in production. This tool now delivers the same advanced cleaning performance as single-wafer tools, and at the same time up to 75% reduction of sulfuric acid use. We also believe the unique approach of our new panel products – including the Ultra ECP ap-p Horizontal Plating tool, the Ultra C vac-p Flux Cleaning tool, and the Ultra C bev-p Bevel Etching Tool – position ACM to become a significant contributor to the global adoption of AI chip manufacturing.”

Dr. Wang continued, "Looking ahead, we anticipate continued growth of our business in mainland China through market share gains and new product ramps. We have begun initial operations at our Lingang facility, and we remain committed to support major customers in the US, Europe, and Southeast Asia. Our near-term outlook has improved, and as a result, we have raised our 2024 revenue outlook."

	Three Months Ended September 30,
	GAAP								Non-GAAP(1)
		2024				2023				2024				2023
	(dollars in thousands, except EPS)
Revenue	$	203,976			$	168,569			$	203,976			$	168,569
Gross margin		51.4	%			52.5	%			51.6	%			52.9	%
Income from operations	$	44,184			$	33,173			$	56,065			$	43,754
Net income attributable to ACM Research, Inc.	$	30,904			$	25,679			$	42,372			$	37,579
Basic EPS	$	0.49			$	0.43			$	0.68			$	0.62
Diluted EPS	$	0.45			$	0.39			$	0.63			$	0.57

	Nine Months Ended September 30,
	GAAP								Non-GAAP(1)
		2024				2023				2024				2023
	(dollars in thousands, except EPS)
Revenue	$	558,647			$	387,402			$	558,647			$	387,402
Gross margin		50.3	%			50.9	%			50.6	%			51.1	%
Income from operations	$	107,009			$	72,465			$	147,801			$	87,131
Net income attributable to ACM Research, Inc.	$	72,547			$	59,649			$	114,490			$	78,743
Basic EPS	$	1.17			$	0.99			$	1.85			$	1.31
Diluted EPS	$	1.07			$	0.90			$	1.70			$	1.19

(1)

Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on short-term investments.

Outlook

ACM has raised its revenue guidance range for fiscal year 2024 to a range of $725 million to $745 million from the prior range of $695 million to $735 million. This expectation is based on ACM management’s current assessment of the continuing impact from international trade policy, together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field, among other factors.

Operating Highlights and Recent Announcements

• Shipments. Total shipments in the third quarter of 2024 were $261 million, up 23% from the third quarter of 2023. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.

• Major Performance Breakthrough for Flagship Ultra C Tahoe Cleaning Tool. The upgraded Ultra C Tahoe now achieves the performance of standalone single-wafer cleaning tools on low-to-medium temperature sulfuric peroxide mix (SPM) processes. The hybrid architecture delivers enhanced cleaning performance, high throughput, and process flexibility, with an up to 75% reduction in chemical consumption. The upgraded Ultra C Tahoe is now in production at several high-volume customer facilities in mainland China. Additional logic and memory customers are evaluating the tool, and we expect to deliver additional units through the end 2024.
• Launched Ultra C bev-p Panel Bevel Etching Tool for Panel-Level Packaging Applications. The new tool is specifically designed for bevel etching and cleaning in copper-related processes and is capable of handling both the front and back side etching within a single system. This capability enhances process efficiency and product reliability.
• Received Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center. ACM has received purchase orders for four wafer-level packaging tools, including two from a U.S.-based customer and two from a U.S.-based research and development (R&D) center. The four tools support a range of advanced packaging processes and are scheduled for delivery in the first half of 2025.
• Completed Purchase of Commercial Facility in Oregon. On October 1, 2024, ACM completed the purchase of a 39,500 square foot facility, including a 5,200 square foot functional clean room. This facility is intended to augment ACM’s current Oregon facility and further expand ACM’s R&D and demonstration capability in the U.S. market.

• Opening of R&D and Production Facility. On October 20, 2024, ACM Shanghai celebrated the official opening of its new R&D and production facility in Lingang, China.
  

Third Quarter 2024 Financial Summary

Unless otherwise noted, the following figures refer to the third quarter of 2024 and comparisons are with the third quarter of 2023.

• Revenue was $204.0 million, up 21%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, partly offset by lower sales of advanced packaging (excluding ECP), services & spares.
• Gross margin was 51.4% versus 52.5%. Non-GAAP gross margin, which excludes stock-based compensation, was 51.6% versus 52.9%. Gross margin exceeded ACM’s long-term business model range of 40% to 45%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
• Operating expenses were $60.7 million, an increase of 10%. Operating expenses as a percentage of revenue decreased to 29.7% from 32.8%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $49.2 million, up 8.5%. Non-GAAP operating expenses as a percentage of revenue decreased to 24.1% from 26.9%.
• Operating income was $44.2 million, compared to $33.2 million. Operating margin was 21.7% compared to 19.7%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $56.1 million, compared to $43.8 million. Non-GAAP operating margin, which excludes stock-based compensation, was 27.5% compared to 26.0%.
• Unrealized gain (loss) on short-term investments was $0.4 million, compared to an unrealized gain (loss) of $(1.3) million. Unrealized gain (loss) reflects the change in market value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
• Income tax expense was $4.0 million, compared to $0.7 million.
• Net income attributable to ACM Research, Inc. was $30.9 million, compared to $25.7 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $42.4 million, compared to $37.6 million.
• Net income per diluted share attributable to ACM Research, Inc. was $0.45, compared to $0.39. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $0.63, compared to $0.57.
• Cash and cash equivalents, plus restricted cash and short-term and long-term time deposits were $369.1 million at September 30, 2024, compared to $366.8 million at June 30, 2024.
  

Conference Call Details

A conference call to discuss results will be held on Thursday, November 7, 2024, at 8:00 a.m. Eastern Time (9:00 p.m. China Time). To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number allowing access to the conference call. This pre-registration process is designed by the operator to reduce delays due to operator congestion when accessing the live call.

Online Registration: https://register.vevent.com/register/BIcf4dbc584cf54892966d5353590ab648

Participants who have not pre-registered may join the webcast by accessing the link at ir.acmrcsh.com/events.

A live and archived webcast will be available on the Investors section of the ACM website at www.acmrcsh.com.

Use of Non-GAAP Financial Measures

ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted earnings per share exclude the effect of stock-based compensation and unrealized gain (loss) on short-term investments, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of GAAP to non-GAAP Financial Measures.”

ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.

While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.

Forward-Looking Statements

Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words are intended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings ACM makes with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.

About ACM Research, Inc.
ACM develops, manufactures and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing, vertical furnace processes, Track and PECVD, which are critical to advanced semiconductor device manufacturing and wafer-level packaging. ACM is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield. For more information, visit www.acmrcsh.com.

© ACM Research, Inc. ULTRA C and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.

For investor and media inquiries, please contact:

In the United States:	The Blueshirt Group
	Steven C. Pelayo, CFA
	(360)808-5154
	steven@blueshirtgroup.co
In China:	The Blueshirt Group Asia
	Gary Dvorchak, CFA
	+86 (138) 1079-1480
	gary@blueshirtgroup.co

ACM RESEARCH, INC. Condensed Consolidated Balance Sheets
	September 30, 2024				December 31, 2023
	(Unaudited)
	(In thousands)
Assets
Current assets:
Cash and cash equivalents	$	333,472			$	182,090
Restricted cash		1,782				1,083
Short-term time deposits		20,304				80,524
Short-term investment		20,351				21,312
Accounts receivable, net		370,589				283,186
Other receivables		57,849				40,065
Inventories, net		628,720				545,395
Advances to related party		1,453				2,432
Prepaid expenses		10,794				20,023
Total current assets		1,445,314				1,176,110
Property, plant and equipment, net		250,099				201,848
Land use right, net		8,320				8,367
Operating lease right-of-use assets, net		5,680				7,026
Intangible assets, net		2,838				2,538
Long-term time deposits		13,517				40,818
Deferred tax assets		13,400				20,271
Long-term investments		33,655				27,880
Other long-term assets		21,352				6,050
Total assets	$	1,794,175			$	1,490,908
Liabilities and Equity
Current liabilities:
Short-term borrowings	$	33,795			$	31,335
Current portion of long-term borrowings		30,670				6,783
Related party accounts payable		15,392				11,407
Accounts payable		170,810				141,814
Advances from customers		215,678				181,368
Deferred revenue		10,138				3,687
Income taxes payable		6,796				6,401
FIN-48 payable		8,991				12,149
Other payables and accrued expenses		115,388				102,951
Current portion of operating lease liability		2,377				2,764
Total current liabilities		610,035				500,659
Long-term borrowings		106,069				53,952
Long-term operating lease liability		3,303				4,262
Other long-term liabilities		5,685				5,873
Total liabilities		725,092				564,746
Commitments and contingencies
Equity:
Stockholders’ equity:
Class A Common stock		6				6
Class B Common stock		1				1
Additional paid-in capital		669,540				629,845
Retained earnings		229,374				156,827
Statutory surplus reserve		30,060				30,060
Accumulated other comprehensive loss		(40,815	)			(49,349	)
Total ACM Research, Inc. stockholders’ equity		888,166				767,390
Non-controlling interests		180,917				158,772
Total equity		1,069,083				926,162
Total liabilities and equity	$	1,794,175			$	1,490,908

ACM RESEARCH, INC. Condensed Consolidated Statements of Operations and Comprehensive Income
	Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
	(Unaudited)
	( In thousands, except share and per share data)
Revenue	$	203,976			$	168,569			$	558,647			$	387,402
Cost of revenue		99,142				80,055				277,908				190,263
Gross profit		104,834				88,514				280,739				197,139
Operating expenses:
Sales and marketing		15,759				16,803				47,067				37,579
Research and development		27,837				26,151				77,723				60,244
General and administrative		17,054				12,387				48,940				26,851
Total operating expenses		60,650				55,341				173,730				124,674
Income from operations		44,184				33,173				107,009				72,465
Interest income		2,967				2,152				7,122				6,283
Interest expense		(1,208	)			(640	)			(2,923	)			(1,984	)
Realized gain from sale of short-term investments		171				656				444				8,569
Unrealized gain (loss) on short-term investments		413				(1,319	)			(1,151	)			(4,428	)
Other income (expense), net		(5,164	)			(2,150	)			(727	)			156
Income (loss) from equity method investments		1,316				(160	)			101				3,728
Income before income taxes		42,679				31,712				109,875				84,789
Income tax expense		(4,007	)			(718	)			(17,712	)			(11,235	)
Net income		38,672				30,994				92,163				73,554
Less: Net income attributable to non-controlling interests		7,768				5,315				19,616				13,905
Net income attributable to ACM Research, Inc.	$	30,904			$	25,679			$	72,547			$	59,649
Comprehensive income (loss):
Net income		38,672				30,994				92,163				73,554
Foreign currency translation adjustment, net of tax		17,089				4,015				10,376				(21,831	)
Comprehensive Income		55,761				35,009				102,539				51,723
Less: Comprehensive income attributable to non-controlling interests		10,842				7,768				21,458				11,882
Comprehensive income (loss) attributable to ACM Research, Inc.	$	44,919			$	27,241			$	81,081			$	39,841
Net income attributable to ACM Research, Inc. per common share:
Basic	$	0.49			$	0.43			$	1.17			$	0.99
Diluted	$	0.45			$	0.39			$	1.07			$	0.90
Weighted average common shares outstanding used in computing per share amounts:
Basic		62,500,903				60,219,218				62,017,257				59,953,144
Diluted		66,671,526				65,450,941				66,512,143				64,834,051

ACM RESEARCH, INC. Total Revenue by Product Category and by Region
	Three Months Ended September 30,						Nine Months Ended September 30,
	2024			2023			2024			2023
	(Unaudited)
	($ in thousand)
Single wafer cleaning, Tahoe and semi-critical cleaning equipment	$	160,985		$	132,417		$	423,676		$	281,559
ECP (front-end and packaging), furnace and other technologies		34,600			25,508			99,362			71,223
Advanced packaging (excluding ECP), services & spares		8,391			10,644			35,609			34,620
Total Revenue By Product Category	$	203,976		$	168,569		$	558,647		$	387,402

	Three Months Ended September 30,						Nine Months Ended September 30,
	2024			2023			2024			2023
Mainland China	$	203,672		$	168,302		$	552,642		$	375,528
Other Regions		304			267			6,005			11,874
Total Revenue By Region	$	203,976		$	168,569		$	558,647		$	387,402

ACM RESEARCH, INC. Reconciliation of GAAP to Non-GAAP Financial Measures

As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (“SBC”) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude unrealized gain (loss) on short-term investments. The following tables reconcile gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:

	Three Months Ended September 30,
		2024															2023
	Actual (GAAP)				SBC				Other non- operating adjustments			Adjusted (Non-GAAP)				Actual (GAAP)				SBC				Other non- operating adjustments				Adjusted (Non-GAAP)
	(In thousands)
Revenue	$	203,976			$	-			$	-		$	203,976			$	168,569			$	-			$	-			$	168,569
Cost of revenue		(99,142	)			(447	)			-			(98,695	)			(80,055	)			(588	)			-				(79,467	)
Gross profit		104,834				(447	)			-			105,281				88,514				(588	)			-				89,102
Gross margin		51.4	%			0.2	%			-			51.6	%			52.5	%			0.3	%			-				52.9	%
Operating expenses:
Sales and marketing		(15,759	)			(2,594	)			-			(13,165	)			(16,803	)			(2,543	)			-				(14,260	)
Research and development		(27,837	)			(3,373	)			-			(24,464	)			(26,151	)			(3,421	)			-				(22,730	)
General and administrative		(17,054	)			(5,467	)			-			(11,587	)			(12,387	)			(4,029	)			-				(8,358	)
Total operating expenses		(60,650	)			(11,434	)			-			(49,216	)			(55,341	)			(9,993	)			-				(45,348	)
Income (loss) from operations	$	44,184			$	(11,881	)		$	-		$	56,065			$	33,173			$	(10,581	)		$	-			$	43,754
Unrealized gain (loss) on short-term investments		413				-				413			-				(1,319	)			-				(1,319	)			-
Net income (loss) attributable to ACM Research, Inc.	$	30,904			$	(11,881	)		$	413		$	42,372			$	25,679			$	(10,581	)		$	(1,319	)		$	37,579
Basic EPS	$	0.49										$	0.68			$	0.43											$	0.62
Diluted EPS	$	0.45										$	0.63			$	0.39											$	0.57

	Nine Months Ended September 30,
	2024																2023
	Actual (GAAP)				SBC				Other non- operating adjustments				Adjusted (Non-GAAP)				Actual (GAAP)				SBC				Other non- operating adjustments				Adjusted (Non-GAAP)
	(In thousands)
Revenue	$	558,647			$	-			$	-			$	558,647			$	387,402			$	-			$	-			$	387,402
Cost of revenue		(277,908	)			(2,020	)			-				(275,888	)			(190,263	)			(838	)			-				(189,425	)
Gross profit		280,739				(2,020	)			-				282,759				197,139				(838	)			-				197,977
Gross margin		50.3	%			0.4	%			-				50.6	%			50.9	%			0.2	%			-				51.1	%
Operating expenses:
Sales and marketing		(47,067	)			(8,645	)			-				(38,422	)			(37,579	)			(3,405	)			-				(34,174	)
Research and development		(77,723	)			(12,082	)			-				(65,641	)			(60,244	)			(4,831	)			-				(55,413	)
General and administrative		(48,940	)			(18,045	)			-				(30,895	)			(26,851	)			(5,592	)			-				(21,259	)
Total operating expenses		(173,730	)			(38,772	)			-				(134,958	)			(124,674	)			(13,828	)			-				(110,846	)
Income (loss) from operations	$	107,009			$	(40,792	)		$	-			$	147,801			$	72,465			$	(14,666	)		$	-			$	87,131
Unrealized gain (loss) on short-term investments		(1,151	)			-				(1,151	)			-				(4,428	)			-				(4,428	)			-
Net income (loss) attributable to ACM Research, Inc.	$	72,547			$	(40,792	)		$	(1,151	)		$	114,490			$	59,649			$	(14,666	)		$	(4,428	)		$	78,743
Basic EPS	$	1.17											$	1.85			$	0.99											$	1.31
Diluted EPS	$	1.07											$	1.70			$	0.90											$	1.19

FAQ

What was ACM Research (ACMR) revenue in Q3 2024?

ACM Research reported revenue of $204 million in Q3 2024, representing a 21% increase from Q3 2023.

What is ACM Research's (ACMR) updated revenue guidance for 2024?

ACM Research raised its fiscal year 2024 revenue guidance to $725-745 million from the previous range of $695-735 million.

How much did ACM Research (ACMR) shipments grow in Q3 2024?

Total shipments in Q3 2024 were $261 million, increasing 23% compared to Q3 2023.

What was ACM Research's (ACMR) earnings per share in Q3 2024?

ACM Research reported diluted earnings per share of $0.45 in Q3 2024, compared to $0.39 in Q3 2023.